Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 10/20 | 0.55 |
| ▸ | GPR34 | Q9UPC5 | 7/20 | 0.55 |
| ▸ | GPR174 | Q9BXC1 | 6/20 | 0.55 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.51 |
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27566251 | 1.00 | P2RY10 (0.55) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| SCHEMBL28180536 | 1.00 | P2RY10 (0.55) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| Phosphine SCHEMBL28117726 | 0.99 | P2RY10 (0.54) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| SCHEMBL28263018 | 0.99 | P2RY10 (0.54) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| Hydrochloric Acid SCHEMBL28242944 | 0.99 | P2RY10 (0.54) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| SCHEMBL14092739 | 0.92 | P2RY10 (0.53) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| Dimethylaminoethanol SCHEMBL28331606 | 0.92 | P2RY10 (0.47) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| Choline SCHEMBL28243279 | 0.91 | FABP3 (0.54) | P2RY10GPR34GPR174LPAR3LPAR1 | |
| SCHEMBL14092747 | 0.88 | P2RY10 (0.51) | P2RY10GPR34GPR174 | |
| SCHEMBL417532 | 0.87 | P2RY10 (0.73) | P2RY10GPR34GPR174LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 93405 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118359666-A | Tetravalent cisplatin prodrug, liposome and application thereof | 杭州佰因泰医药科技有限公司 | 2024-07-19 | — | — | CN | claimed |
| WO-2024151957-A1 | FORSKOLIN AND METHODS OF USE THEREOF FOR PREVENTING OR TREATING OBESITY AND/OR METABOLIC DISEASES OR DISORDERS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-07-18 | — | — | WO | claimed |
| EP-3383383-B1 | MEDIUM CHAIN TRIGLYCERIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME, AND/OR EPILEPSY | NESTLE SA (CH) | 2024-07-17 | — | — | EP | claimed |
| EP-4398731-A1 | COMPOUNDS AND FORMULATIONS FOR PROTECTIVE COATINGS | Apeel Technology, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| EP-4398882-A1 | LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY | BioNTech SE (DE) | 2024-07-17 | — | — | EP | claimed |
| EP-4399163-A1 | LIPID FORMULATIONS FOR THE PREPARATION OF HEALTH INGREDIENT-CONTAINING HOT DRINKS | Liposama Health B.V. (NL) | 2024-07-17 | — | — | EP | claimed |
| EP-4398942-A1 | LINKERS FOR USE IN ANTIBODY DRUG CONJUGATES | Orum Therapeutics Inc. (KR) | 2024-07-17 | — | — | EP | claimed |
| CN-118355032-A | BCMA antibodies and uses thereof | 山东先声生物制药有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-12037600-B2 | Transfection complexes and methods of using the same | MOLECULAR TRANSFER, INC. (US) | 2024-07-16 | — | — | US | claimed |
| CN-118355033-A | Compositions and methods comprising anti-NRP 2a antibodies | ATYR 医药公司 | 2024-07-16 | — | — | CN | claimed |
| EP-0087993-A1 | Pulverized mixture of lipid and hydrophobic constituents, process for preparing them, hydrated lipid lamellar phases and process for preparing them, pharmaceutical or cosmetic compositions containing hydrated lamellar lipid phases | PARFUMS CHRISTIAN DIOR (FR) | 1983-09-07 | — | — | EP | claimed |
| US-4397846-A | Storage-stable lipid vesicles and method of preparation | WEINER MURRAY (US) | 1983-08-09 | — | — | US | claimed |
| US-4388412-A | Immunoassay of phospholipid, such as phosphatidylcholine, in fluids such as amniotic | HANA BIOLOGICS, INC. (US) | 1983-06-14 | — | — | US | claimed |
| EP-0072286-A1 | Organic amide compounds derived from nitrogenous lipids | FIDIA S.p.A. (IT) | 1983-02-16 | — | — | EP | claimed |
| US-4332796-A | MICROCRYSTALS COATED WITH MIXTURES OF PHOSPHOLIPIDS AND NONIONIC SURFACTANTS | LABORATORIOS BAGO S.A. (AR) | 1982-06-01 | — | — | US | claimed |
| EP-0038979-A1 | Process for preparing ethylcellulose microcapsules | Tanabe Seiyaku Co., Ltd. (JP) | 1981-11-04 | — | — | EP | claimed |
| EP-0001104-B1 | MODIFIED INTACT ERYTHROCYTES, BLOOD OR BLOOD PRESERVES CONTAINING THEM AND PROCESS FOR THEIR PREPARATION | Studiengesellschaft Kohle mbH (DE) | 1981-05-20 | — | — | EP | claimed |
| US-4224179-A | Process for the preparation of liposomes in aqueous solution | BATTELLE MEMORIAL INSTITUTE (CH) | 1980-09-23 | — | — | US | claimed |
| US-4089801-A | Process for the preparation of liposomes | BATTELLE MEMORIAL INSTITUTE (CH) | 1978-05-16 | — | — | US | claimed |
| US-4078052-A | Large unilamellar vesicles (LUV) and method of preparing same | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH, EDUCATION AND WELFARE (US) | 1978-03-07 | — | — | US | claimed |